XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders' Equity - Stock Option Activity (Details) - USD ($)
3 Months Ended 6 Months Ended
May 30, 2024
Jun. 30, 2024
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Number of Options          
Granted (in shares) 1,697,712        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures          
Authorized shares under the plan (in shares)   8,150,000 8,150,000    
Stock repurchased and retired during period, shares (in shares) 1,697,712        
Shares acquired, average cost per share (in dollars per share) $ 3.51        
Share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value (in dollars per share) $ 3.51        
Options to purchase Common Stock          
Weighted-average assumptions          
Risk-free interest rate     4.06% 3.61%  
Dividend yield (as a percent)     0.00% 0.00%  
Expected volatility (as a percent)     106.00% 109.00%  
Expected term     5 years 9 months 18 days 5 years 3 months 18 days  
Number of Options          
Balance outstanding at the beginning of the period (in shares)     6,650,954    
Granted (in shares)     1,899,096    
Exercised (in shares)     (133,614)    
Forfeited and expired (in shares)     (65,314)    
Balance outstanding at the end of the period (in shares)   8,351,122 8,351,122    
Exercisable at the end of the period (in shares)   4,124,114 4,124,114    
Vested and expected to vest (in shares)   8,121,830 8,121,830    
Weighted Average Exercise Price Per Share          
Balance outstanding at the beginning of the period (in USD per share)     $ 4.27    
Granted (in USD per share)     3.40    
Exercised (in USD per share)     2.69    
Forfeited and expired (in USD per share)     13.96    
Balance outstanding at the end of the period (in USD per share)   $ 4.02 4.02    
Exercisable at the end of the period (in USD per share)   4.85 4.85    
Vested and expected to vest (in USD per share)   $ 4.05 $ 4.05    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures          
Options outstanding, intrinsic value   $ 1,169,885 $ 1,169,885   $ 23,926
Exercisable at the end of the period, intrinsic value   468,750 468,750    
Vested and expected to vest, intrinsic value   $ 1,118,569 $ 1,118,569    
Inducement Grant Stock Options          
Number of Options          
Granted (in shares)   1,380,248      
Equity Incentive Plan 2021          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures          
Number of remaining shares available for issuance (in shares)   3,153,005 3,153,005